Catalyst Wire Dossier Catalyst Wire Dossier

Humira 100 mg/mL

adalimumab · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Humira 100 mg/mL, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects [Phase 1]

See pricing